slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 57,181-57,210
Pages 3,679
Rows per page 30
Component
57,181-57,210 of 110,355
05
The chart displays TTM (Trailing Twelve Months) data points. The callout highlights the Y/Y growth rate.Amazon | Results Presentation Deck | 18 slides · Amazon
Conference presentation Investor relations Beat · Market SizeLoop · Logic Chain1 hit
07
The chart displays a clear upward trend in net sales over five quarters.Amazon | Results Presentation Deck | 18 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
10
The chart highlights a 97% Y/Y growth and 93% F/X adjusted growth.Amazon | Results Presentation Deck | 18 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
02
Asos | Results Presentation Deck | 31 slidesAsos | Results Presentation Deck | 31 slides · Asos
Conference presentation Investor relations Beat · Problem1 hit
03
Includes a footnote regarding adjustments for acquisition costs.Asos | Results Presentation Deck | 31 slides · Asos
Conference presentation Investor relations Beat · Problem1 hit
06
Includes footnotes explaining adjustments for acquisitions and IFRS16.Asos | Results Presentation Deck | 31 slides · Asos
Conference presentation Investor relations Beat · Financials1 hit
10
The slide uses a table format to compare regional performance metrics.Asos | Results Presentation Deck | 31 slides · Asos
Conference presentation Investor relations Beat · Financials1 hit
12
The slide uses three distinct charts to illustrate shifts in consumer behavior during the COVID-19 period.Asos | Results Presentation Deck | 31 slides · Asos
Conference presentation Investor relations 1 hit
06
Includes footnotes explaining abbreviations and specific financial impacts.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a table to categorize pipeline progress into regulatory approval, submission, and Phase III data readouts.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
08
The slide uses a waterfall-style logic to decompose revenue growth sources.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
09
The slide uses two side-by-side tables to compare revenue, growth percentages, and ratios across different business segments.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a Venn-diagram-like visual to show the synergy between the two companies.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses stacked bar charts to show revenue composition over time (Q1 2018 - Q1 2021).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The chart shows revenue breakdown by product (Fasenra, Symbicort, Pulmicort, Other) from Q1 2018 to Q1 2021.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
The slide uses a stacked bar chart to distinguish between China and EMs ex China revenue over time.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Includes footnotes regarding exchange rates, CER, and specific expense definitions.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes a trend line on the bar chart and a credit rating footnote.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide uses a three-column layout to categorize progress into clinical data, rollout, and antibody development.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
The slide uses a column-based layout to map specific drug candidates to disease areas.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to show the evolution from legacy product (Synagis) to clinical trial results (Phase IIb and Phase III) for nirsevimab.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Loop · Before After1 hit
30
The slide uses a split-layout to contrast early-stage development (left) with late-stage/marketed assets (right).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Slide 32 of a presentation, likely from AstraZeneca given the drug names.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
The slide uses a grid-based layout to map drug indications against patient segments and treatment lines.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The slide uses a two-column layout to contrast early-stage pipeline assets with late-stage/marketed assets.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
The slide uses a matrix-style layout to organize pipeline events by time and event type.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Loop · Maturity Curve1 hit
37
The slide uses a three-column layout to summarize key business drivers.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
08
The slide uses a split-screen layout to contrast past performance with future outlook.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Need1 hit
10
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
11
The slide uses a timeline-like list of milestones on the left and a detailed results summary on the right.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Visualization1 hit